Results 31 to 40 of about 6,300 (191)
Severe thrombocytopenia following tirofiban infusion
Indian Journal of Pharmacology, 2011 A 44-year-old man presented with acute coronary syndrome. He was administered glycoprotein IIb/IIIa receptor antagonist (tirofiban) for a left anterior descending artery thrombus detected during percutaneous coronary intervention. He developed very severe thrombocytopenia 24 h after tirofiban infusion with no signs of bleeding.
Kadhim Sulaiman, Prashanth Panduranga
openaire +3 more sources
Mechanical Solitaire Thrombectomy with Low-Dose Booster Tirofiban Injection [PDF]
Neurointervention, 2016 PurposeMechanical thrombectomy using a Solitaire stent has been associated with a high recanalization rate and favorable clinical outcome in intra-arterial thrombolysis.
Duck-Ho Goh +3 more
doaj +1 more source
Frontiers in Neuroscience, 2022 The purpose of this study was to assess the efficacy and safety of the combination of tirofiban with intravenous thrombolysis (IVT) in treating patients with capsular warning syndrome (CWS) who failed to respond to the treatment of intravenous ...
Yunzhu Liu +7 more
doaj +1 more source
Frontiers in Neurology, 2022 IntroductionThe safety and efficacy of tirofiban in intravenous thrombolysis (IVT) bridging to mechanical thrombectomy in patients with acute ischemic stroke (AIS) is unknown.
Wei Li +13 more
doaj +1 more source
Frontiers in NeurologyBackground and purposeAdjunctive tirofiban administration in patients undergoing endovascular treatment (EVT) for acute large vessel occlusion (LVO) has been investigated in several studies. However, the findings are conflict. This study aimed to compare
Zhiping Bu +17 more
doaj +1 more source
THE ROLE OF TIROFIBAN IN ACUTE CORONARY SYNDROMES
International Journal of Clinical Practice, 2000 SUMMARYPlatelet activation and aggregation play an important and essential role in the formation of intracoronary thrombus in acute coronary syndromes (ACS). ACS still carries unacceptably high rates of morbidity and mortality despite intensive antianginal therapy and the wide use of aspirin and heparin.
A, Gomma +3 more
openaire +2 more sources
Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect [PDF]
Journal of Community Hospital Internal Medicine Perspectives, 2020 With the advent of medical technology, coronary angiography is a common practice to evaluate patient for coronary artery disease. Normally, patients undergoing angiogram receive antiplatelets, anticoagulants, and platelet aggregation inhibitor agents. Glycoprotein IIb/IIIa receptor inhibitors are a type of platelets antiaggregant agents that can cause ...
Muhammad Shabbir Rawala +3 more
openaire +4 more sources
SAFETY OF TIROFIBAN FOR PATIENTS WITH ACUTE ISCHEMIC STROKE IN ROUTINE CLINICAL PRACTICE
Российский кардиологический журнал, 2014 Aim. This work aims to study the safety of tirofiban alone and in combination with various treatments in acute ischemic stroke (AIS).Material and methods. 120 AIS patients were included in this study.
Yan-Jun Zhang +3 more
doaj +1 more source
Case report: reuse of tirofiban leads to very severe thrombocytopenia
Frontiers in Cardiovascular Medicine, 2023 BackgroundTelofiban is a class of small molecule non-peptide tyrosine derivatives containing RGD sequences. It is the only platelet surface glycoprotein (GP) IIb/IIIa receptor antagonist (GPI) currently marketed in China.
Yuqing Li +3 more
doaj +1 more source
Clinical Interventions in Aging, 2020 Xiaochuan Huo,1,2,* Ming Yang,1,2,* Ning Ma,1,2 Feng Gao,1,2 Dapeng Mo,1,2 Xiaoqing Li,1,2 Anxin Wang,2,3 Yongjun Wang,2,3 Zhongrong Miao1,2 1Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing ...
Huo X +8 more
doaj